Chronic Lymphocytic Leukemia
- Result Type
- clinical trial
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)
Get personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsGet personalized, coordinated care across Northern California through the Sutter network.
View Patient ResourcesMake appointments, message your doctor and more through our patient portal.
Enroll NowMake appointments, message your doctor and more through our patient portal.
Enroll NowAccess award-winning, comprehensive primary and specialty care for your whole family.
View All ServicesOur contributions to medical research and education lead to better healthcare outcomes.
Research at SutterJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesJoin our robust training programs led by nationally known healthcare leaders.
Explore OpportunitiesExplore the ways we provide innovative, compassionate care through our network.
Learn About Sutter HealthShape the future of healthcare and build your career within our diverse teams.
Find JobsShape the future of healthcare and build your career within our diverse teams.
Find JobsYou are viewing results from Research and Clinical Trials.
2results found for:
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)
Status: Active, Recruiting
Connect® MDS/AML Disease Registry
Status: Active, Recruiting
Check-ups, screenings and sick visits for adults and children.
Expertise and advanced technologies in all areas of medicine.
For serious accidents, injuries and conditions that require immediate medical care.
After-hours, weekend and holiday services.
Convenient walk-in care clinics for your non-urgent health needs.